CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.58 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,000 | +50.0% | 6,452 | +99.0% | 0.00% | – |
| Q2 2023 | $4,000 | -85.2% | 3,242 | -85.1% | 0.00% | – |
| Q1 2023 | $27,000 | – | 21,759 | +144960.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 15 | -99.2% | 0.00% | – |
| Q2 2021 | $4,000 | -60.0% | 1,980 | -48.5% | 0.00% | – |
| Q1 2021 | $10,000 | +66.7% | 3,846 | +32.3% | 0.00% | – |
| Q4 2020 | $6,000 | – | 2,908 | +96833.3% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 3 | -99.5% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 614 | +29.5% | 0.00% | – |
| Q3 2019 | $1,000 | – | 474 | +1002.3% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 43 | -91.5% | 0.00% | – |
| Q1 2017 | $4,000 | -50.0% | 504 | -33.5% | 0.00% | – |
| Q4 2016 | $8,000 | +100.0% | 758 | +157.8% | 0.00% | – |
| Q3 2015 | $4,000 | -20.0% | 294 | -10.6% | 0.00% | – |
| Q2 2015 | $5,000 | – | 329 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,677,194 | $819,000 | 1.02% |
| BVF INC/IL | 6,861,127 | $3,352,000 | 0.16% |
| 5AM Venture Management, LLC | 1,134,511 | $554,000 | 0.14% |
| Knott David M Jr | 635,254 | $310,000 | 0.13% |
| Nantahala Capital Management | 4,819,090 | $2,355,000 | 0.12% |
| West Family Investments, Inc. | 368,910 | $180,000 | 0.07% |
| Stonepine Capital Management, LLC | 208,443 | $102,000 | 0.05% |
| JEPPSON WEALTH MANAGEMENT, LLC | 181,075 | $88,000 | 0.04% |
| Ground Swell Capital, LLC | 11,397 | $6,000 | 0.01% |
| Point72 Asset Management, L.P. | 4,200,000 | $2,052,000 | 0.01% |